Hypoxia-responsive bilirubin supramolecular nanoprodrugs for targeted photothermal-chemotherapy†
Abstract
A bilirubin supramolecular nanoprodrug (SCBR/TPZ) with enhanced cellular uptake towards the HepG2 cell line was constructed based on host–guest recognition, which provided an innovative strategy to design a hypoxia-responsive BR supramolecular nanoprodrug for lactose-targeted photothermal-chemotherapy (PTT-CT) with a synergistic effect towards HepG2.